Double redirects

Jump to navigation Jump to search

This page lists pages that redirect to other redirect pages. Each row contains links to the first and second redirect, as well as the target of the second redirect, which is usually the "real" target page to which the first redirect should point. Crossed out entries have been solved.

Showing below up to 50 results in range #1,021 to #1,070.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Toprol XL indications and usage → Metoprolol succinate#Adult Indications and Dosage → Metoprolol succinate (tablet)
  2. Toprol XL dosage and administration → Metoprolol succinate#Adult Indications and Dosage → Metoprolol succinate (tablet)
  3. Toprol XL contraindications → Metoprolol succinate#Contraindications → Metoprolol succinate (tablet)
  4. Toprol XL warnings and precautions → Metoprolol succinate#Warnings → Metoprolol succinate (tablet)
  5. Toprol XL adverse reactions → Metoprolol succinate#Adverse Reactions → Metoprolol succinate (tablet)
  6. Toprol XL drug interactions → Metoprolol succinate#Drug Interactions → Metoprolol succinate (tablet)
  7. Toprol XL use in specific populations → Metoprolol succinate#Use in Specific Populations → Metoprolol succinate (tablet)
  8. Toprol XL overdosage → Metoprolol succinate#Overdosage → Metoprolol succinate (tablet)
  9. Toprol XL description → Metoprolol succinate#Structure → Metoprolol succinate (tablet)
  10. Toprol XL clinical pharmacology → Metoprolol succinate#Pharmacology → Metoprolol succinate (tablet)
  11. Toprol XL clinical studies → Metoprolol succinate#Clinical Studies → Metoprolol succinate (tablet)
  12. Toprol XL how supplied storage and handling → Metoprolol succinate#How Supplied → Metoprolol succinate (tablet)
  13. Toprol XL patient counseling information → Metoprolol succinate#Patient Counseling Information → Metoprolol succinate (tablet)
  14. Toprol XL labels and packages → Metoprolol succinate#Package and Label Display Panel → Metoprolol succinate (tablet)
  15. Toprol XL → Metoprolol succinate → Metoprolol succinate (tablet)
  16. Toprol XL dosage forms and strengths → Metoprolol succinate#How Supplied → Metoprolol succinate (tablet)
  17. Toprol XL nonclinical toxicology → Metoprolol succinate#Nonclinical Toxicology → Metoprolol succinate (tablet)
  18. Toprol XL pill images and characteristics → Metoprolol succinate#Images → Metoprolol succinate (tablet)
  19. Toprol XL black box warning → Metoprolol succinate#Warnings → Metoprolol succinate (tablet)
  20. Toprol XL mechanism of action → Metoprolol succinate#Pharmacology → Metoprolol succinate (tablet)
  21. Toprol XL price → Metoprolol succinate#Price → Metoprolol succinate (tablet)
  22. Toprolxl XL → Metoprolol succinate → Metoprolol succinate (tablet)
  23. MERS infection → Middle east respiratory syndrome coronavirus infection → Middle East respiratory syndrome coronavirus infection
  24. Middle east respiratory syndrome infection → Middle east respiratory syndrome coronavirus infection → Middle East respiratory syndrome coronavirus infection
  25. Minoxidil (patient information) → Minoxidil Oral (patient information) → Minoxidil oral (patient information)
  26. Assessment of Severity of MR → Mitral regurgitation assessment of severity → Mitral regurgitation stages
  27. Mitral Regurgitation Ventriculogram → Mitral regurgitation ventriculogram → Mitral regurgitation cardiac catheterization
  28. Carcinosarcoma → Mixed Mullerian tumor → Mixed mullerian tumor
  29. MMMT → Mixed Mullerian tumor → Mixed mullerian tumor
  30. Mixed Müllerian tumor → Mixed Mullerian tumor → Mixed mullerian tumor
  31. Carcinosarcoma of the uterus → Mixed Mullerian tumor → Mixed mullerian tumor
  32. Sarcomatoid carcinoma of the uterus → Mixed Mullerian tumor → Mixed mullerian tumor
  33. Malignant mesodermal mixed tumor → Mixed Mullerian tumor → Mixed mullerian tumor
  34. Metaplastic carcinoma → Mixed Mullerian tumor → Mixed mullerian tumor
  35. Combined fat and carbohydrate-induced hyperlipemia → Mixed hyperlipoproteinemia → Hyperlipoproteinemia type 5
  36. Familial hyperchylomicronemia with hyperprebetalipoproteinemia → Mixed hyperlipoproteinemia → Hyperlipoproteinemia type 5
  37. Late-onset hyperchylomicronemia → Mixed hyperlipoproteinemia → Hyperlipoproteinemia type 5
  38. Late onset hyperchylomicronemia → Mixed hyperlipoproteinemia → Hyperlipoproteinemia type 5
  39. Mixed hyperlipemia → Mixed hyperlipoproteinemia → Hyperlipoproteinemia type 5
  40. Type V hyperlipidemia → Mixed hyperlipoproteinemia → Hyperlipoproteinemia type 5
  41. Monoblastic leukemia → Monocytic leukemia → AML
  42. Monocytic leukemias → Monocytic leukemia → AML
  43. Monocytic leukaemia → Monocytic leukemia → AML
  44. Mononuclear → Mononuclear cells → Monocyte
  45. Urticaria-deafness-amyloidosis → Muckle-Wells syndrome → Cryopyrin-associated periodic syndrome
  46. Muckle-Wells Syndrome → Muckle-Wells syndrome → Cryopyrin-associated periodic syndrome
  47. Multiple endocrine neoplasia type 2b → Multiple endocrine neoplasia type 2a → Multiple endocrine neoplasia type 2
  48. MEA type 4 → Multiple endocrine neoplasia type 4 → Multiple endocrine neoplasia type 1 pathophysiology#MEN type 4
  49. Multiple endocrine neoplasms type 4 → Multiple endocrine neoplasia type 4 → Multiple endocrine neoplasia type 1 pathophysiology#MEN type 4
  50. Multiple endocrine adenomatosis, type 4 → Multiple endocrine neoplasia type 4 → Multiple endocrine neoplasia type 1 pathophysiology#MEN type 4

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:DoubleRedirects"